These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 10640262)

  • 1. Metronidazole, its bioactive metabolites and acne.
    Bannatyne RM
    Curr Med Res Opin; 1999; 15(4):298-9. PubMed ID: 10640262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic susceptibility of Propionibacterium acnes isolated from acne vulgaris in Korea.
    Song M; Seo SH; Ko HC; Oh CK; Kwon KS; Chang CL; Kim MB
    J Dermatol; 2011 Jul; 38(7):667-73. PubMed ID: 21352337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical considerations in the treatment of acne vulgaris and other inflammatory skin disorders: focus on antibiotic resistance.
    Leyden JJ; Del Rosso JQ; Webster GF
    Cutis; 2007 Jun; 79(6 Suppl):9-25. PubMed ID: 17649854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The bacteriology of acne vulgaris and antimicrobial susceptibility of Propionibacterium acnes and Staphylococcus epidermidis isolated from acne lesions.
    Nishijima S; Kurokawa I; Katoh N; Watanabe K
    J Dermatol; 2000 May; 27(5):318-23. PubMed ID: 10875198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lactobacillus paraplantarum THG-G10 as a potential anti-acne agent with anti-bacterial and anti-inflammatory activities.
    Cha H; Kim SK; Kook M; Yi TH
    Anaerobe; 2020 Aug; 64():102243. PubMed ID: 32712375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of two plant extracts against acne vulgaris: Initial results of microbiological tests and cell culture studies.
    Kılıç S; Okullu SÖ; Kurt Ö; Sevinç H; Dündar C; Altınordu F; Türkoğlu M
    J Cosmet Dermatol; 2019 Aug; 18(4):1061-1065. PubMed ID: 30414245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-vitro investigation of anti-acne properties of Mangifera indica L. kernel extract and its mechanism of action against Propionibacterium acnes.
    Poomanee W; Chaiyana W; Mueller M; Viernstein H; Khunkitti W; Leelapornpisid P
    Anaerobe; 2018 Aug; 52():64-74. PubMed ID: 29906773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro antibiotic susceptibility patterns of Propionibacterium acnes isolated from acne patients: an Egyptian university hospital-based study.
    Abdel Fattah NS; Darwish YW
    J Eur Acad Dermatol Venereol; 2013 Dec; 27(12):1546-51. PubMed ID: 23279041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between Propionibacterium acnes biotypes and Jumi-haidoku-to.
    Higaki S; Kitagawa T; Kagoura M; Morohashi M; Yamagishi T
    J Dermatol; 2000 Oct; 27(10):635-8. PubMed ID: 11092266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metronidazole and acne.
    Bannatyne RM; Harnett NM
    Acta Derm Venereol; 1976; 56(4):307-8. PubMed ID: 60028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial susceptibility of Propionibacterium acnes isolated from acne vulgaris.
    Kurokawa I; Nishijima S; Kawabata S
    Eur J Dermatol; 1999; 9(1):25-8. PubMed ID: 9920982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of macrolide therapy on patients with acne vulgaris].
    Akamatsu H
    Jpn J Antibiot; 2001 Feb; 54 Suppl A():109-12. PubMed ID: 11439886
    [No Abstract]   [Full Text] [Related]  

  • 13. Resistance of propionibacteria to antibiotics used in the treatment of acne.
    Brown JM; Poston SM
    J Med Microbiol; 1983 Aug; 16(3):271-80. PubMed ID: 6224016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic resistance in the topical treatment of acne vulgaris.
    Leyden JJ
    Cutis; 2004 Jun; 73(6 Suppl):6-10. PubMed ID: 15228128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Esc-1GN shows therapeutic potentials for acne vulgaris and inflammatory pain.
    Ye T; Wu J; Xu Z; Chai J; Zeng Q; Zeng B; Gao Y; Guo R; Chen X; Xu X
    J Pept Sci; 2020 Aug; 26(8):e3269. PubMed ID: 32558003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Myrtus communis extract enriched in myrtucummulones and ursolic acid reduces resistance of Propionibacterium acnes biofilms to antibiotics used in acne vulgaris.
    Feuillolay C; Pecastaings S; Le Gac C; Fiorini-Puybaret C; Luc J; Joulia P; Roques C
    Phytomedicine; 2016 Mar; 23(3):307-15. PubMed ID: 26969384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Propionibacterium acnes and antimicrobial resistance in acne.
    Dessinioti C; Katsambas A
    Clin Dermatol; 2017; 35(2):163-167. PubMed ID: 28274353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of propionibacterium acnes by bacteriocin-like inhibitory substances (BLIS) produced by Streptococcus salivarius.
    Bowe WP; Filip JC; DiRienzo JM; Volgina A; Margolis DJ
    J Drugs Dermatol; 2006 Oct; 5(9):868-70. PubMed ID: 17039652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility of Propionibacterium acnes and Staphylococcus epidermidis to killing by MPO-halide system products. Implication for taurine bromamine as a new candidate for topical therapy in treating acne vulgaris.
    Marcinkiewicz J; Biedroń R; Białecka A; Kasprowicz A; Mak M; Targosz M
    Arch Immunol Ther Exp (Warsz); 2006; 54(1):61-8. PubMed ID: 16642259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The antibiotic susceptibility of Propionibacterium acnes: a 15-year bacteriological study and retrospective evaluation.
    Kurokawa I; Nishijima S; Asada Y
    J Dermatol; 1988 Apr; 15(2):149-54. PubMed ID: 2971698
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.